Virology News and Research

Latest Virology News and Research

WHO using new bivalent oral polio vaccine in Afghanistan

The WHO on Tuesday launched a vaccination campaign in Afghanistan that will use "a new and more effective polio vaccine" for the first time, Reuters reports (Nebehay, 12/15).

16 Dec 2009

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

GlaxoSmithKline plc and NanoBio Corporation today announced an exclusive licensing agreement in the United States and Canada for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of cold sores. Developed by NanoBio, NB-001 provides significant antimicrobial activity against the virus that causes cold sores, herpes labialis.

16 Dec 2009

Pennsylvania expands H1N1 vaccination program to everyone

Certified healthcare providers who have already immunized patients most at risk of complications from the H1N1 flu virus may now offer the vaccine to anyone who wants it, the Department of Health announced today.

16 Dec 2009

Immune system produces neutralizing antibodies capable of blocking HIV, says study

Scientists seeking to understand how to make an AIDS vaccine have found the cause of a major roadblock. It turns out that the immune system can indeed produce cells with the potential to manufacture powerful HIV-blocking antibodies - but at the same time, the immune system works equally hard to make sure these cells are eliminated before they have a chance to mature.

16 Dec 2009

Infectious virus particles can bind to the surface of red blood cells: MHRP researchers

Free infectious HIV-1 is widely thought to be the major form of the virus in the blood of infected persons. U.S. Military HIV Research Program (MHRP) researchers, however, have demonstrated that essentially all of the infectious virus particles can bind to the surface of red blood cells isolated from each of 30 normal (non-infected) human donors.

16 Dec 2009

Drug monitoring may provide alternative treatments for patients with severe H1N1

An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.

16 Dec 2009

Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness

Drug trafficking and use are fueling the spread of HIV/AIDS in Kenya, according to a recent report by the U.N. Security Council, the Nation reports. "A statement from the council's Presidency currently … states that Afghan heroin was being imported, causing a dramatic increase in heroin addiction and spreading HIV/AIDS in the slums of Nairobi and Mombasa, Kenya's two main cities," the newspaper writes.

15 Dec 2009

Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system

Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER(TM) HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software. LAB TRACKER(TM) HIV is a full-service, scalable software platform designed to meet the complex disease-management needs of health care providers who are treating people living with HIV/AIDS.

15 Dec 2009

Novartis submits JOULFERON MAA to the EMEA

Human Genome Sciences, Inc. today announced that Novartis has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN™) for the treatment of chronic hepatitis C. In November 2009, HGS submitted a Biologics License Application (BLA) for ZALBIN to the FDA in the United States.

15 Dec 2009

Dangers of H1N1 flu contaminated touch surfaces tour kicks-off

Dr. Bob Arnot kicks-off a national educational tour on the silent threat of H1N1 flu contaminated touch surfaces and the new biotechnology in EPA-registered SpectraSan 24 that kills bacteria, fungus and viruses including Influenza A (H1N1 or Swine Flu).

15 Dec 2009

CDC has distributed 3,177,900 doses of H1N1 flu vaccine to Pennsylvania till date

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 3,177,900 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.

15 Dec 2009

University of Alberta researchers make math and science real for high-school students

University of Alberta education professor Stephen Norris and mathematics professor Gerda de Vries used the virus as a theoretical tool when they designed materials for use in an advanced high-school math course.

15 Dec 2009

Researchers advance in developing a vaccine against AIDS disease

Led by Matthias J. Schnell, Ph.D., director of the Jefferson Vaccine Center, the researchers found that a rabies virus-based vaccine administered to monkeys protected against the simian equivalent of the HIV virus (SIV). The data were published in the journal Vaccine.

15 Dec 2009

Microbicide does not reduce women's risk of HIV infection, study shows

Pro 2000, a vaginal microbicide gel designed to reduce women's risk of HIV infection, showed "no evidence that it reduces the risk of HIV infection," according to the results of a series of clinical trials in Africa, Britain's Medical Research Council (MRC) said on Monday, Reuters reports.

15 Dec 2009

FDA grants EUA for DxNA’s 2009 H1N1 influenza virus diagnostic test

DxNA announced today that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for use in DxNA's GeneSTAT(TM) detection platform.

14 Dec 2009

Study supports the use of SinoFresh Nasal Spray to prevent and decrease H1N1 virus

SinoFresh HealthCare Products, Inc. announced the recent successful initial pilot animal study of the SinoFresh Nasal Spray product for use in preventing and decreasing the severity of H1N1 ("swine flu") virus.

14 Dec 2009

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers.

14 Dec 2009

Clinical trial of 2009 H1N1 influenza vaccine

HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.

13 Dec 2009

By understanding how gene works, scientists may find ways to prevent, cure diabetes

A gene commonly studied by cancer researchers has been linked to the metabolic inflammation that leads to diabetes.

12 Dec 2009

About 47M infected, 10,000 dead from H1N1 in U.S., CDC says

U.S. health officials on Thursday announced nearly 10,000 people in the U.S. had died from H1N1 (swine flu) since the virus was first reported in April, the New York Times reports.

11 Dec 2009

Virology News and Research

Latest Virology News and Research

WHO using new bivalent oral polio vaccine in Afghanistan

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

Pennsylvania expands H1N1 vaccination program to everyone

Immune system produces neutralizing antibodies capable of blocking HIV, says study

Infectious virus particles can bind to the surface of red blood cells: MHRP researchers

Drug monitoring may provide alternative treatments for patients with severe H1N1

Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness

Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system

Novartis submits JOULFERON MAA to the EMEA

Dangers of H1N1 flu contaminated touch surfaces tour kicks-off

CDC has distributed 3,177,900 doses of H1N1 flu vaccine to Pennsylvania till date

University of Alberta researchers make math and science real for high-school students

Researchers advance in developing a vaccine against AIDS disease

Microbicide does not reduce women's risk of HIV infection, study shows

FDA grants EUA for DxNA’s 2009 H1N1 influenza virus diagnostic test

Study supports the use of SinoFresh Nasal Spray to prevent and decrease H1N1 virus

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

Clinical trial of 2009 H1N1 influenza vaccine

By understanding how gene works, scientists may find ways to prevent, cure diabetes

About 47M infected, 10,000 dead from H1N1 in U.S., CDC says

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production